Form 4 for TELA TELA Bio, Inc.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001062993-23-004533 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-23 | 2023-02-21 | TELA | Smeykal Megan | CAO, Ctrl | A - Grant | $0.00 | +9,400 | 21.5K | +78% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | A | A | 9,400 | $0.00 | 21,489 | D | — | — | (F1) These restricted stock units will vest in four equal annual installments beginning on February 21, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. |